Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective was to assess the effect of 3-month treatment of low and standard doses
of fenofibrate in combination with stable dose of metformin on fasting triglycerides levels
in patients with type 2 diabetes and dyslipidemia.